SIC
RCUS icon

SJS Investment Consulting’s Arcus Biosciences RCUS Stock Holding History

SJS Investment Consulting’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5
Closed -$77 – 1689
2024
Q3 		$77 Hold
5
– – ﹤0.01% 1588
2024
Q2 		$77 Hold
5
– – ﹤0.01% 1594
2024
Q1 		$95 Hold
5
– – ﹤0.01% 1573
2023
Q4 		$96 Sell
5
-2
-29% -$32 ﹤0.01% 1554
2023
Q3 		$126 Buy
7
+1
+17% +$20 ﹤0.01% 1518
2023
Q2 		$122 Buy
+6
New +$114 ﹤0.01% 1484
2023
Q1 		– Sell
-5
Closed -$103 – 1620
2022
Q4 		$103 Buy
5
+2
+67% +$55 ﹤0.01% 1492
2022
Q3 		$0 Buy
+3
New +$79 ﹤0.01% 1456

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

SJS Investment Consulting's RCUS Position: Q4 2024 in Review

SJS Investment Consulting sold out of Arcus Biosciences (RCUS) in Q4 2024, closing a stake of 5 shares — an estimated $77 sold.

SJS Investment Consulting first reported a position in RCUS in Q3 2022 and held it in 8 quarters. The position peaked at $126 in Q3 2023. 186 funds tracked by Wall St. Rank hold RCUS as of Q4 2024.

  • SJS Investment Consulting reported no remaining Arcus Biosciences position as of Q4 2024 after selling out during the quarter.
  • SJS Investment Consulting sold 5 Arcus Biosciences shares in Q4 2024, an estimated $77.
  • SJS Investment Consulting first reported a position in Arcus Biosciences in Q3 2022 and held it in 8 quarters.
  • SJS Investment Consulting's Arcus Biosciences position peaked at $126 in Q3 2023.
  • 186 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2024.

Based on SJS Investment Consulting's 13F filing for Q4 2024, filed 21 Jan 2025.